- Miller, Bruce;
- Nagarajan, Srikantan;
- Ranasinghe, KG;
- Hinkley, LB;
- Beagle, AJ;
- Mizuiri, D;
- Dowling, AF;
- Honma, SM;
- Finucane, MM;
- Scherling, C;
- Miller, BL;
- Nagarajan, SS
Understanding neural network dysfunction in neurodegenerative disease is imperative to effectively develop network-modulating therapies. In Alzheimer's disease (AD), cognitive decline associates with deficits in resting-state functional connectivity of dif
